Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Sol-Gel Technologies (NASDAQ:SLGL) through any online brokerage.
Other companies in Sol-Gel Technologies’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Sol-Gel Technologies has a consensus price target of $145.00.
The stock price for Sol-Gel Technologies (NASDAQ: SLGL) is $75.64 last updated October 6, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Sol-Gel Technologies.
Sol-Gel Technologies does not have any upcoming earnings scheduled.
There is no upcoming split for Sol-Gel Technologies.
Sol-Gel Technologies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.